{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "71844",
      "recalling_firm": "Pharmedium Services, LLC",
      "address_1": "150 N Field Dr Ste 350",
      "address_2": "N/A",
      "postal_code": "60045-2506",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1822-2015",
      "product_description": "PHENYLephrine HCl, 40 mg added to 250 mL 0.9% Sodium Chloride Injection USP (160 mcg per mL), packaged in 250 ml bags, Rx only, PharMEDium Services, LLC, 12620 W. Airport Blvd., Sugar Land, TX  77478, NDC# 61553-169-50",
      "product_quantity": "24 bags",
      "reason_for_recall": "Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).",
      "recall_initiation_date": "20150128",
      "center_classification_date": "20150923",
      "termination_date": "20170127",
      "report_date": "20150930",
      "code_info": "Lot #:  14309095S, Exp 02/03/15; 14311008S, Exp 02/05/15"
    }
  ]
}